Teva Pharmaceutical Industries Limited

TEVA

$38.98−$0.21 −0.54%At close · September 18

Price1Y range $18.34 – $39.25

Valuations

Estimation history is only available for connected users.

Financial Ratios

vs. 4-yr trend

RATIO TREND TTM

Free Cash Flow Ratiosgreen ≥ 5%

'23 → 2025

—

Net Income Margin Ratiosgreen ≥ 15%

'23 → 2025

—

Return on Equity Ratiosgreen ≥ 15%

'23 → 2025

—

Return on Asset Ratiosgreen ≥ 7%

'23 → 2025

—

Growth

Total Revenue YoY Growth 4.13%

Cash from Ops YoY Growth 36.55%

Ask about TEVA

Ask the documents

No research uploaded for this stock yet. Check back later.

Key stats

FCF / Sales 6.7%

Net margin 8.2%

Return on equity 20.8%

Profile

Sector Health Care

Industry Pharmaceuticals, Biotechnology & Life Sciences

Country Israel

Exchange NYSE

Website Visit site

About

Teva Pharmaceutical Industries is transforming into an innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years it has innovated in neuroscience and immunology while providing complex generic medicines, biosimilars and pharmacy brands worldwide. The NYSE line is an ADR; the shares are also listed on the Tel Aviv Stock Exchange.